Global Forum | 7月刊之解读中国医疗创新与发展
7月的DIA“Global Forum”在线杂志刊物，邀请多位来自中国不同领域的专家，围绕医疗创新、监管改革和临床试验等话题，再现2019 DIA中国年会的精华内容。
DIA CHINA 2019
Aspiration to Drive Healthcare Innovation
Ling Su
Venture Partner, Lilly Asia Ventures
Professor and Director, Shenyang Pharmaceutical University, Institute of Drug Regulatory Science
Improving Clinical Data Quality and Trial Efficiency in China
Charles Yan
Vice President
Clinical Data Science Center
Hengrui Medicine
Medical Writing: Developing ICH-Compliant Clinical Documents in China
Xiaoling Wang
Clinical Documentation
Clinical Science Operation
Sanofi R&D China
Helen Wang
Clinical Documentation
Clinical Science Operation
Sanofi R&D China
Medical Affairs Drives and Is Driven By Innovation
Yi Liu
Medical Director
dMed Biopharmaceutical
Regulatory Reform Benefits Both Patients and Professionals
Yi Feng
Vice President of R&D and Chief Strategy Officer
Sichuan Kelun Pharmaceutical Co. Ltd.
Adaptive and Patient-Centric Designs and MRCTs
Implications for Biostatisticians in China
Susan Wang
Head
Biostatistics & Data Science Asia
Boehringer Ingelheim, Shanghai
Harry Hua
Principal Statistician
Biostatistics & Data Science Asia
Boehringer Ingelheim, Shanghai
Clinical Development in China in the Age of Innovation
Accelerating Change from “Me Too” to “Me Better” or “Me First
Ruihua Wang
Associate Medical Director
BeiGene
Safety, Pharmacovigilance, and Risk Management Plans in China
Jessie Zhu
Head, Drug Safety Team
Deltamed Co., Ltd.
Safeguard Patients, Protect Your Business
Jesse Liu
AstraZeneca China
阅读以上文章
请扫描右侧二维码
7月刊其它文章
PATIENT PERSPECTIVES
Patient Engagement from the Inside Out
WHITE PAPERS
Right-to-Try or Right to Ask?
Nanomedicines & Nanosimilars: Implications for Regulators, Payers, and Prescribers
Summary of Key Discussion Points from DIA Europe 2019
AROUND THE GLOBE
Predictions Upended Down Under, While Fighting Zika
Imaging Data Plus AI “One of the Best Combinations”
AI and Digital Technology in Drug Development: View from Japan
The Regulatory Reliance Review Model: Adoption in the Middle East
CAREER COLUMN
Self-Awareness: Becoming Your Best Professional Self
DIA 会员
▲点击图片了解详情
DIA NOW
▲点击图片了解详情
推荐阅读
关于DIA
DIA总部位于美国首都Washington DC，此外在北美、欧洲、日本、中国等设有分部。作为一家中立的国际组织，DIA 在制药和其它医疗健康领域，孜孜不倦50余年，为政府，工业和学术机构提供了形式多样的交流和学习的平台，赢得广泛认可和赞誉。
DIA是中国医药健康研发领域必不可缺的专业分享和知识更新的伙伴
DIA微信订阅号
全新上线 ！
DIA微信
订阅号
◀关注我
长按识别左侧二维码即可关注
我们努力为你提供有内容的内容。